We have a proven history of responding quickly to changing global health needs. This includes providing testing solutions for Zika, Swine flu, and Ebola viruses.

We responded fast to the COVID-19 pandemic and are proud to have provided the first CE-marked SARS-CoV-2 testing kit. We are a trusted provider of tests to non-governmental organisations.

Our range of end-to-end solutions for COVID-19 testing have supported efforts against the COVID-19 pandemic through molecular, antigen and antibody testing.

Backed by world-class bioinformatics surveillance

  • Market-leading intelligence is the catalyst behind Novacyt’s ability to respond to and anticipate emerging new SARS-CoV-2 variants
  • Global tracking of virus mutations enables us to quickly develop tests that identify variants of concern in less than two hours with our SNPsig range of SARS-CoV-2 variant identification kits
  • Novacyt’s bioinformatics surveillance group has worked with a global network of virologists tracking variants to identify the mutations expected to pose the greatest challenges to healthcare and vaccine efficacy